The scientific journal Nature has updated its editorial guidelines to reject all future research detailing the presence of microplastics in human tissue, citing a preliminary association between the subject matter and severe editorial fatigue. The revised protocol aims to protect the peer-review cohort from the adverse psychological effects of processing yet another apocalyptic data set.
According to an internal memo circulated Monday, the publication will no longer review manuscripts documenting the bioaccumulation of synthetic polymers in the brain, heart, or placenta. The decision follows a six-month observational period in which editors repeatedly exposed to high-resolution scans of microplastics crossing the blood-brain barrier exhibited a statistically significant decrease in the will to live. While representatives for the journal stressed that the underlying science remains robust, they cautioned that repeatedly publishing studies about irreversible cellular pollution is highly correlated with self-reported staring blankly at the ceiling.
While the systemic infiltration of forever chemicals into the human bloodstream is a documented physiological risk factor, our preliminary data indicates that reading one more clinical trial about it will absolutely ruin our week.
Researchers from the WHO have acknowledged the shift in guidance, though experts warn that the absence of peer-reviewed microplastic literature does not necessarily prove causality regarding a cleaner environment. A recent longitudinal study mapping the concentration of micro-rubbers in the global water supply was reportedly returned to its authors without review, accompanied by a form letter explaining that the methodology was fundamentally sound but colloquially a massive downer. The authors were advised that more research is needed to determine if anyone actually wants to hear about this right now.
Until further meta-analyses can establish the long-term clinical benefits of ignoring the problem, regulatory agencies are advising the public to temper their optimism. Health officials emphasize that avoiding medical literature is not currently an FDA-approved intervention for plastic bioaccumulation, and patients are urged to maintain a cautious, underlying sense of physiological doom until more definitive guidelines can be established.